Single agent post-transplantation cyclophosphamide as GVHD prophylaxis after HLA-matched related BMT for pediatric and young adult patients with hematologic malignancies

High dose cyclophosphamide given after HLA-matched related and unrelated allogeneic bone marrow transplantation (BMT) for patients with hematologic malignancies is effective single agent graft-versus-host disease (GVHD) prophylaxis in adults. Data describing outcomes for pediatric and young adult pa...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Biol Blood Marrow Transplant
Autores principales: Jacoby, Elad, Chen, Allen, Loeb, David M., Gamper, Christopher J., Zambidis, Elias, Llosa, Nicolas J., Huo, Jeffrey, Cooke, Kenneth R., Jones, Rick, Fuchs, Ephraim, Luznik, Leo, Symons, Heather J.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2015
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4706497/
https://ncbi.nlm.nih.gov/pubmed/26343947
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2015.08.034
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares